Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, ...

FDA Recall #D-0536-2023 — Class II — March 16, 2023

Recall #D-0536-2023 Date: March 16, 2023 Classification: Class II Status: Terminated

Product Description

Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-504-01; NDC Unit Dose: 60687-504-11, barcode (01) 003 60687 504 11 7.

Reason for Recall

Failed Dissolution Specifications: Out of specification dissolution results above specified values.

Recalling Firm

Amerisource Health Services LLC — Columbus, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

695 cartons

Distribution

Nationwide in the USA

Code Information

Lots: 1008622, 1010026, Exp 2/29/24

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated